[ad_1]
Valsartan Survey
Made in China, 2.8% of Total Production and Imports
NDMA is a 2A substance, a potential human carcinogen at the International Institute for Cancer Research of the WHO
In addition, the company has suspended provisional imports and suspended sales of raw materials manufactured by Chinese director Jiang Hua Hua, who are allowed to use valsartan as raw material. In the past three years, the total volume of manufacture and import of valsartan is 484,682 ㎏, and the Chinese manufacturer Valsartan accounts for 2.8% of the total volume of manufacturing and import during the same period .
KFDA is conducting a survey on impurities. Therefore, we will take the necessary steps for collection and disposal. "Although this preliminary step has not yet been identified for the detection of NDMA and the risk of the product, it has been done proactively to protect consumers."
The pharmacist knows that all drugs containing valsartan According to the order of the doctor, the pharmacy can not take prescription.As the warning "prescription prohibition" is registered in the system "service of "safe use", it can not be prescribed by the doctor.
If you have any indications of side effects suspected to be related to the product, you can report it to the Korea Drug Safety Agency (1644-6233, www.drugsafe.or .kr).
Copyright © Tianji Daily Reprint and Redistribution Ban
Source link